Validated LC–MS/MS Methods for The Determination of Dapagliflozin, A Sodium-Glucose Co-Transporter 2 Inhibitor in Normal and ZDF Rat Plasma
- 26 November 2010
- journal article
- research article
- Published by Taylor & Francis in Bioanalysis
- Vol. 2 (12) , 2001-2009
Abstract
Background: Dapagliflozin is an inhibitor of sodium-glucose co-transporter 2 (SGLT-2) in development for the treatment of Type 2 diabetes. To support toxicology studies, LC–MS/MS methods were developed and validated for the quantitation of dapagliflozin in rat plasma. Results: The assay uses solid phase extraction and LC–MS/MS analysis in negative ion electrospray ionization mode. Because dapagliflozin readily forms adducts in the presence of formic acid, the mobile phases were simple mixtures of water and acetonitrile. The assay was validated in the concentration range of 5–2000 ng/ml with good intra- and inter-day precisions and acceptable sample stability. Conclusion: The validated assay was successfully applied to the quantitation of dapagliflozin in plasma in support of preclinical studies in both normal and diabetic rats.Keywords
Funding Information
- Bristol-Myers Squibb Company
This publication has 9 references indexed in Scilit:
- In Vitro Characterization and Pharmacokinetics of Dapagliflozin (BMS-512148), a Potent Sodium-Glucose Cotransporter Type II Inhibitor, in Animals and HumansDrug Metabolism and Disposition, 2010
- A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin SensitizersDiabetes Care, 2009
- Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy SubjectsClinical Pharmacology & Therapeutics, 2009
- Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 DiabetesDiabetes Care, 2008
- Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic RatsDiabetes, 2008
- New features on the fragmentation and differentiation of C ‐glycosidic flavone isomers by positive electrospray ionization and triple quadrupole mass spectrometryRapid Communications in Mass Spectrometry, 2008
- Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 DiabetesJournal of Medicinal Chemistry, 2008
- A sensitive and selective LC–MS–MS method for simultaneous determination of picroside-I and kutkoside (active principles of herbal preparation picroliv) using solid phase extraction in rabbit plasma: Application to pharmacokinetic studyJournal of Chromatography B, 2005
- Mass spectrometry in the structural analysis of flavonoidsJournal of Mass Spectrometry, 2004